首页|M2巨噬细胞来源的TNFSF13通过激活IRF8对胶质母瘤细胞替莫唑胺耐药的影响

M2巨噬细胞来源的TNFSF13通过激活IRF8对胶质母瘤细胞替莫唑胺耐药的影响

扫码查看
目的 探讨M2巨噬细胞来源的肿瘤坏死因子配体超家族成员13(TNFSF13)通过调控干扰素调节因子8(IRF8)对胶质母瘤(GBM)细胞替莫唑胺(TMZ)耐药的影响。方法 免疫组织化学法(IHC)检测正常脑组织和GBM组织中 TNFSF13的表达,ELISA检测M0型巨噬细胞和M2型巨噬细胞条件培养基(CM)中TNFSF13的表达。M0-CM和M2-CM用于培养U251敏感(U251/S)细胞和U251耐药(U251/R)细胞。TMZ处理组同时加入800 μmol/L的TMZ。U251/R细胞分为如下组:con组、M2vector-CM 组、M2vector-CM+TMZ 组、M2TNFSF13-CM 组、M2TNFSF13-CM+TMZ 组、si-IRF8 组、si-IRF8+M2TNFSF13-CM 组。CCK-8检测细胞活力并计算IC50值,Transwell实验检测细胞侵袭,流式细胞术检测凋亡,Western blot检测IRF8的表达。构建裸鼠移植瘤模型并且将裸鼠分为如下组:U251+M2si-NC组、U251+M2si-TNFSF13组、U251+M2si-NC+TMZ 组、U251+M2si-TNFSF13+TMZ 组。检测各组成瘤体积和质量,免疫组化检测各组肿瘤组织中TNFSF13和CD206的表达。结果 与癌旁组织以及M0-CM比较,癌组织以及M2-CM中TNFSF13的表达上调。与M0-CM组相比,M2-CM组中U251/S和U251/R细胞TMZ的IC50值和细胞侵袭数目均显著上调(均P<0。05)。在M2巨噬细胞中过表达TNFSF13能够促进U251/R细胞TMZ的IC50值,促进细胞侵袭、抑制细胞凋亡(均P<0。05)。过表达TNFSF13促进IRF8的表达,敲低IRF8能够减弱过表达TNFSF13介导的U251/R对TMZ耐药。体内研究显示,敲低TNFSF13与TMZ单独或联合处理显著抑制肿瘤生长、降低TNFSF13和CD206的表达。结论 M2巨噬细胞来源的TNFSF13通过激活IRF8促进GBM细胞TMZ耐药。
M2 macrophage-derived TNFSF13 affects temozolomide resistance in glioblastoma cells by activating IRF8
Objective To investigate the impact of tumor necrosis factor ligand superfamily member 13(TNFSF13)derived from M2 macrophages on temozolomide(TMZ)resistance via regulating interferon regulatory factor 8(IRF8)in glioblastoma(GBM)cells.Methods Immunohistochemistry(IHC)was used to detect the ex-pression of TNFSF13 in normal brain tissues and GBM tissues.ELISA was used to measure the expression of TN-FSF13 in the conditioned media(CM)of M0-type macrophages and M2-type macrophages.M0-CM and M2-CM were used to culture U251 sensitive(U251/S)and resistant(U251/R)cells.The TMZ treatment group was also treated with 800 μmol/L TMZ.The U251/R cells were divided into the following groups:con group,M2vector-CM group,M2vector-CM+TMZ group,M2TNFSF13-CM group,M2TNFSF13-CM+TMZ group,si-IRF8 group,and si-IRF8+M2TNFSF13-CM group.CCK-8 assay was used to detect cell viability and calculate the IC50 value.Transwell assay was used to detect cell invasion.Flow cytometry was used to detect apoptosis.Western blot was used to detect the ex-pression of IRF8.Nude mouse xenograft models were constructed and the nude mice were divided into the following groups:U251+M2si-NC group,U251+M2si-TNFSF13 group,U251+M2si-NC+TMZ group,U251+M2si-TNFSF13+TMZ group.The tumor volume and mass of each group were measured,and IHC was used to detect the expression of TN-FSF13 and CD206 in tumor tissues of each group.Results Compared with adjacent tissues and M0-CM,the ex-pression of TNFSF13 was up-regulated in cancer tissues and M2-CM.Compared with the M0-CM group,the IC50 value of TMZ and the number of cell invasions in U251/S and U251/R cells in the M2-CM group significantly in-creased(all P<0.05).Overexpression of TNFSF13 in M2 macrophages could promote the IC50 value of TMZ in U251/R cells,promote cell invasion,and inhibit cell apoptosis(all P<0.05).Overexpression of TNFSF13 pro-moted the expression of IRF8,and knocking down IRF8 could attenuate the TMZ resistance of U251/R mediated by overexpression of TNFSF13.In vivo studies showed that knocking down TNFSF13 alone or combined with TMZ treatment significantly inhibited tumor growth and reduced the expression of TNFSF13 and CD206.Conclusion TNFSF13 derived from M2 macrophages promotes TMZ resistance in GBM cells by activating IRF8.

M2 macrophagesglioblastomaTNFSF13IRF8temozolomidedrug resistance

刘文辉、洪文明、陈佳星、萨日娜、刘娟、张晓丽

展开 >

内蒙古医科大学第二附属医院药学部,呼和浩特 010010

安徽医科大学第一附属医院神经外科,合肥 230022

M2巨噬细胞 胶质母瘤 TNFSF13 IRF8 替莫唑胺 耐药

2024

安徽医科大学学报
安徽医科大学

安徽医科大学学报

CSTPCD北大核心
影响因子:1.095
ISSN:1000-1492
年,卷(期):2024.59(11)